e-learning
resources
ERJ
2014
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Microparticles and vascular dysfunction in obstructive sleep apnoea
Trzepizur Wojciech, Martinez Maria Carmen, Priou Pascaline, Andriantsitohaina Ramaroson, Gagnadoux Frédéric
Source:
Eur Respir J 2014; 44: 207-216
Journal Issue:
July
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Trzepizur Wojciech, Martinez Maria Carmen, Priou Pascaline, Andriantsitohaina Ramaroson, Gagnadoux Frédéric. Microparticles and vascular dysfunction in obstructive sleep apnoea. Eur Respir J 2014; 44: 207-216
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on acute decompensated pulmonary hypertension
Adherence predictors to positive airway pressure (PAP) treatment in patients with obstructive sleep apnea (OSA)
The search for realistic evidence on the outcomes of obstructive sleep apnoea
Related content which might interest you:
Endothelial dysfunction in patients with obstructive sleep apnea
Source: Annual Congress 2011 - Obstructive sleep apnoea: inflammation and metabolism
Year: 2011
Circulating microparticles and endothelial dysfunction in obstructive sleep apnea syndrome
Source: Annual Congress 2008 - Metabolic syndrome and systemic inflammation in obstructive sleep apnoea
Year: 2008
The vascular micromilieu in obstructive sleep apnoea
Source: Eur Respir J 2005; 25: 780-782
Year: 2005
Endothelial function in obstructive sleep apnea syndrome
Source: Annual Congress 2011 - Cardiometabolic and neurocognitive changes in obstructive sleep apnoea
Year: 2011
Mechanisms and assessment of vascular damage in obstructive sleep apnoea
Source: Annual Congress 2013 –Yernault Lecture “Obstructive sleep apnoea as a model of systemic disease” followed by “Vascular tree and obstructive sleep apnoea”
Year: 2013
Association of vascular endothelial dysfunction with disease severity in obstructive sleep apnoea
Source: Annual Congress 2008 - Cardiovascular complications in obstructive sleep apnoea
Year: 2008
Markers of liver dysfunction in patients with obstructive sleep apnea
Source: Annual Congress 2011 - Obstructive sleep apnoea: inflammation and metabolism
Year: 2011
Vascular reactivity in patients with mild-moderate obstructive sleep apnoea
Source: Eur Respir J 2007; 30: Suppl. 51, 332s
Year: 2007
Impact of obstructive sleep apnea and obesity on endothelial dysfunction in children
Source: Virtual Congress 2020 – Respiratory physiology and sleep: from neonates to adults
Year: 2020
Unrecognised obstructive sleep apnoea is common in severe peripheral arterial disease
Source: Eur Respir J 2013; 41: 616-620
Year: 2013
Endothelial dysfunction in patients with obstructive sleep apnea independent of metabolic syndrome
Source: Annual Congress 2008 - Cardiovascular complications in obstructive sleep apnoea
Year: 2008
Resistant arterial hypertension and obstructive sleep apnea syndrome
Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA II
Year: 2012
Pulmonary hypertension and obstructive sleep apnea syndrome -Marmara Universitypediatric sleep laboratory experience
Source: Virtual Congress 2020 – Respiratory physiology and sleep: what is new?
Year: 2020
Circulating cell-derived microparticles in patients with minimally symptomatic obstructive sleep apnoea
Source: Eur Respir J 2009; 33: 574-580
Year: 2009
Inspiratory muscle dysfunction in patients with severe obstructive sleep apnoea
Source: Eur Respir J 2010; 35: 373-380
Year: 2010
Unrecognised systemic hypertension in patients with obstructive sleep apnoea
Source: Eur Respir J 2006; 28: Suppl. 50, 643s
Year: 2006
Cardiac arrythmias in chronic obstructive pulmonary disease and obstructive sleep apnoea syndrome
Source: Eur Respir J 2006; 28: Suppl. 50, 645s
Year: 2006
Airway inflammation in patients with obstructive sleep apnea syndrome
Source: Eur Respir J 2002; 20: Suppl. 38, 274s
Year: 2002
Pathophysiological consequences of obstructive sleep apnoea
Source: Annual Congress 2006 - Obstructive sleep apnoea and cardiovascular diseases
Year: 2006
Metabolic disturbances in overlap syndrome (obstructive sleep apnoea + chronic obstructive pulmonary disease) and obstructive sleep apnoea (OSA) patients
Source: Annual Congress 2010 - Clinical aspects of sleep apnoea
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept